The row came as Italy prepared the next stage of its gradual easing of a national lockdown imposed three months ago to fight the spread of the deadly virus.
The scientists at University of Oxford’s Jenner Institute and the Oxford Vaccine Group have expressed concerns that they may not be able to complete their research since the virus is diminishing in the UK. The Oxford scientists group should consider commencing simultaneous trials in Africa, at Kenya and in Asia, say India, where the virus is yet very strong. The trials should go on.
Scientists still predict a safe and effective vaccine against SARS-CoV-2, the virus that causes COVID-19 could take at least 12-18 months to develop, according to a new report from a section of the media.
Volunteers will undergo a medical evaluation of their current health to determine their eligibility for the trials according to global health policies and study guidelines. E
Preliminary projections make the availability of one or several vaccines seem possible by autumn 2020," the Robert Koch Institute said in a statement on its website, citing a global effort to bring immunisations to market.
Prime Minister Boris Johnson has sparked accusations of putting Brexit before health by rejecting an invitation to join an EU scheme to procure a coronavirus vaccine.
The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates have reached a major milestone with over 5,000 volunteers have now received their first vaccination.
It is encouraging to read that the Oxford vaccine is showing positive results (Oxford COVID-19 vaccine produces immune response in early human trial, July 20, Gulf Today).
Intelligence agencies in the three nations alleged that the hacking group APT29, also known as Cozy Bear and said to be part of the Russian intelligence service, is attacking academic and pharmaceutical research institutions involved in COVID-19 vaccine development.